Clinical Study
Basal-Supported Oral Therapy with Sitagliptin Counteracts Rebound Hyperglycemia Caused by GLP-1 Tachyphylaxis
Table 1
Baseline characteristics of patients.
| ||||||||||||||||||||||||||
Data are shown as mean ± SD. BMI: body mass index; SBP: systolic blood pressure; DBP: diastolic blood pressure. HbA1c is presented as National Glycohemoglobin Standardization Program (NGSP) value. |